BridgeBio Pharma, Inc. (BBIO) · Fund holders
Which of the 64 well-known fund managers followed here own BridgeBio Pharma, from the 13F each files after a quarter's end, and what each did in its latest quarter.
Held by
4
of 64 funds
Their stake
$888.33M
together
Bought
2
1 new, 1 added
Sold
2
0 sold out
The funds
| Fund | Share of its portfolio | Shares | Value | Latest quarter |
|---|---|---|---|---|
| Viking Global Investors2026-06-30 | 2.11% | 9,949,219 | $741.02M | Reduced 16% |
| Point72 Asset Management (Steve Cohen)2026-06-30 | 0.17% | 1,525,782 | $113.64M | New |
| Bridgewater Associates2026-06-30 | 0.14% | 448,143 | $33.38M | Added 73% |
| Polen Capital Management2026-06-30 | 0.00% | 4,002 | $298,069 | Reduced 91% |
A 13F shows a quarter's end and is filed up to 45 days later, so this is not what the funds hold today. All funds ›